Clinical Trials Browser

Bronchiolitis Obliterans Syndrome × axatilimab × 90 days × Clear all

NCT04710576 2026-03-16

AGAVE-201

Phase 2 Active not recruiting

241 enrolled 11 charts 1 FDA

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease